U.S. News

FDA Authorizes Pfizer Booster Shots for Children Between 5 and 11

BOOSTED

Pfizer said its clinical trial data showed that booster shots produced a strong immune response in the age group.

pfizer_5_to_11_n3bk7l
Joseph Prezioso/AFP via Getty

The FDA authorized booster shots of the Pfizer-BioNTech vaccine for children between the ages of 5 and 11. Of the 28 million American children in that age group, more than 8 million have gotten two vaccine doses and are now eligible for a third one after five months.

We think “subscriber” would look good on you. Join now to unlock access.

Don't miss this subscriber exclusive article. 

Got a tip? Send it to The Daily Beast here.